Recalls of levothyroxine and other thyroid hormone replacement drugs, often over sub-potency.
226 recalls in this category, newest first.
Reason Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 88 mcg may have potentially been mislabeled as one of the following drugs: clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: AD46265_1, EXP: 5/15/2014; HYDROXYCHLOROQUINE SULFATE, Tablet, 200 mg, NDC 63304029601, Pedigree: AD70629_10, EXP: 5/29/2014; HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 76439030910, Pedigree: W003438, EXP:
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Reason cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Reason Chemical contamination: emission of strong odor after package was opened.
Reason Chemical contamination: emission of strong odor after package was opened.
Reason Chemical contamination: emission of strong odor after package was opened.
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.